1-3 of 3
Modupe Elebute, MBBS, MD
Close
Sort by
Journal Articles

Continued Benefit From Prolonged Treatment with Eculizumab in 130 Patients with PNH in the UK: Home Delivery of Eculizumab Is Safe, Convenient and Associated with Very High Levels of Patient Satisfaction

Louise M Arnold, RN, BSc, hons, Gemma L Brooksbank, RN, BSc, hons, Richard J Kelly, MBChB, FRCPath, Anita Hill, MBChB, PhD, Stephen John Richards, PhD, FRCPath, Rachel Senior, MPharm, Tracy Downing, Claire McKinley, BSc, James Brown, BMus, Ibrahim Momoh, RN, Modupe Elebute, MBBS, MD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2011) 118 (21): 4368.
https://doi.org/10.1182/blood.V118.21.4368.4368
Published: 2011
Journal Articles

Reduction of Tregs with Expansion of Th1 Cells and Lack of IFN-γ Secretion by GPI Negative T-Cells In PNH

Shahram Kordasti, MD, PhD, Modupe Elebute, MBBS, MD, MRCP, FRCPath, Pilar Perez Abellan, Austin G Kulasekararaj, Janet Hayden, Azim Mohamedali, PHD, Ghulam J. Mufti, DM, FRCP, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2240.
https://doi.org/10.1182/blood.V116.21.2240.2240
Published: 2010
Journal Articles

Low Level Residual Extravascular Haemolysis Is Commom Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria(PNH), but Does Not Affect Transfusion Requirement

Austin G Kulasekararaj, PhD, Dupe Odunsi, PhD, Pramila Krishnamurthy, PhD, Hayden Janet, PhD, Ibrahim Momoh, Ghulam J. Mufti, DM, FRCP, FRCPath, Judith C. W. Marsh, MD, Modupe Elebute, MBBS, MD, MRCP, FRCPath
Journal: Blood
Blood (2010) 116 (21): 4240.
https://doi.org/10.1182/blood.V116.21.4240.4240
Published: 2010